Drugs Starting with C
BioSniper tracks 126 drugs and molecules whose names begin with C — each linked to its developers, clinical trials, indications, and FDA decisions. Data availability reflects the latest successfully ingested source records; source and as-of dates are shown where available.
Browse A–ZC
- cabazitaxel2
- cabotegravir
- cabozantinib
- cabozantinib s-malate1
- cael-101
- caffeine
- calaspargase pegol
- calcitriol
- calcium carbonate
- calcium gluconate
- calderasib
- camibirstat
- camonsertib1
- canakinumab3
- candesartan
- candesartan cilexetil
- cannabidiol
- canvuparatide
- capecitabine
- capivasertib1
- capmatinib1
- carbamazepine1
- carbidopa
- carboprost3
- carfilzomib
- cariprazine1
- carmustine
- carmustine with propylene glycol formulation vi-0609
- carvedilol1
- casdatifan1
- casdozokitug1
- casimersen3
- caspofungin
- ccr2/ccr5 antagonist bms-813160
- cd19-targeted car t cells bz019
- cd8-guided il-2 fusion protein azd6750
- cdk2 inhibitor azd8421
- cdk2 inhibitor eci830
- cdk2 inhibitor incb123667
- cdk4 inhibitor bgb-43395
- cdk7 inhibitor gtaexs6171
- cdx-301
- cedazuridine; decitabine
- cefepime
- ceftriaxone1
- celecoxib
- cemacabtagene ansegedleucel
- cemdisiran
- cemiplimab
- cemsidomide1
- cenerimod
- cenobamate
- cenvacibart
- ceralasertib
- ceritinib2
- cerliponase
- certepetide1
- certociclib
- cetirizine2
- cetrelimab
- cetuximab
- chlorambucil
- chlorhexidine
- chloroprocaine
- chlorpheniramine
- chlorzoxazone1
- cholate
- cholestyramine
- chs-1141
- ciclesonide
- cid-1031
- cilostazol
- ciltacabtagene autoleucel
- cinacalcet2
- cinvanti1
- cipaglucosidase alfa3
- ciprofloxacin
- ciraparantag1
- citalopram
- cladribine
- clarithromycin
- claseprubart
- clesrovimab
- clindamycin
- cln-978
- clobetasol
- clofarabine1
- clofazimine
- clonidine1
- clopidogrel
- clostridia strain formulation ve303
- cmp-001
- cmv pentamer complex proteins/gb-encoding mrna vaccine mrna-1647
- cnty-101
- cobicistat
- cobimetinib1
- colchicine
- colesevelam1
- colestipol1
- comirnaty
- concizumab
- copanlisib
- coramitug1
- corest inhibitor tng2601
- cosibelimab1
- cpi-12051
- cr-001
- crb-701
- cretostimogene grenadenorepvec
- crinecerfont1
- crizanlizumab1
- crizotinib
- crotoxin
- ct-951
- curcumin
- cxc chemokine receptor 2 antagonist azd5069
- cxcr1/2 inhibitor sx-682
- cyclobenzaprine
- cyclophosphamide2
- cyclosporine
- cyfendus
- cyp3a4
- cysteamine
- cytarabine
- cytarabine; daunorubicin
- cytisine
From drug list to evidence case
Define what these drug programs must prove
Choose the developer, phase, trial, indication, and FDA evidence that should count in your drug thesis.